Literature DB >> 30472359

Activation of peripheral group III metabotropic glutamate receptors inhibits pain transmission by decreasing neuronal excitability in the CFA-inflamed knee joint.

Eui Ho Park1, Seung Won Lee2, Sun Wook Moon1, Hye Rim Suh1, Yang In Kim1, Hee Chul Han3.   

Abstract

Peripheral group III metabotropic glutamate receptors (mGluRs) function to modulate pain signaling in inflammatory states. Here, we established in vivo experimental settings, including dynamic weight bearing test and in vivo single nerve recording, to elucidate how the group III mGluRs contribute to inhibiting pain transmission at the peripheral sensory nerve terminal in inflammatory states (1 and 3 days) elicited by Complete Freund's Adjuvant (CFA). As a result, CFA-induced nociceptive behaviors were significantly alleviated after administration of 100 and 200 μM L-AP4 (l-2-amino-4-phosphonobutylate; group III mGluR agonist). In addition, neuronal discharges evoked by 6- and 26-g von Frey filaments at the nerve significantly decreased after administration of 200 μM L-AP4. However, this event was not observed in non-inflammatory state. These results suggest that the group III mGluRs negatively regulate nociceptive behavior and pain transmission by lessening neuronal firing rates at the peripheral nerve in inflammation.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  CFA; Dynamic weight bearing; Group III mGluR; In vivo single nerve recording; Knee joint; Pain transmission

Mesh:

Substances:

Year:  2018        PMID: 30472359     DOI: 10.1016/j.neulet.2018.11.033

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

Review 1.  Recent Advances in the Modulation of Pain by the Metabotropic Glutamate Receptors.

Authors:  Mariacristina Mazzitelli; Peyton Presto; Nico Antenucci; Shakira Meltan; Volker Neugebauer
Journal:  Cells       Date:  2022-08-21       Impact factor: 7.666

Review 2.  Pain Perception and Management: Where do We Stand?

Authors:  Bilal Afridi; Haroon Khan; Esra K Akkol; Michael Aschner
Journal:  Curr Mol Pharmacol       Date:  2021       Impact factor: 3.339

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.